| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2082416 | Drug Discovery Today: Disease Models | 2006 | 6 Pages |
Abstract
Mice have mainly been used in ovarian cancer research as immunodeficient hosts for cell lines derived from the primary tumors and ascites of ovarian cancer patients. These xenograft models have provided a valuable system for pre-clinical trials, however, the genetic complexity of human tumors has precluded the understanding of key events that drive metastatic dissemination. Recently developed immunocompetent, genetically defined mouse models of epithelial ovarian cancer represent significant improvements in the modeling of metastatic disease.
Section editors:Nikolina Vlatkovic and Mark Boyd – University of Liverpool, UK
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biotechnology
Authors
Sanja Šale, Sandra Orsulic,